CDC issues warning after eye drops linked to bacterial infection
The US Centers for Disease Control and Prevention has urged people to discontinue the use of EzriCare Artificial Tears
08 February 2023
The US Centers for Disease Control and Prevention (CDC) has issued a statement urging people to discontinue use of an eye drop that has been linked to a serious bacterial infection.
EzriCare Artificial Tears has been linked with 55 cases of Pseudomonas aeruginosa bacterial infection between May 2022 and January 2023 in 12 different states. The infections have resulted in hospitalisations, vision loss and one death.
Patients who use EzriCare Artificial Tears are advised to immediately discontinue use pending further guidance from the CDC and US Food and Drug Administration.
Patients who have used EzriCare Artificial Tears and are experiencing signs or symptoms of an eye infection are advised to seek medical care.
The Louisiana Department of Health stated: “At this time, CDC does not recommend testing of patients who have used this product and who are not experiencing any signs or symptoms of infection.”
If patients were advised to use EzriCare Artificial Tears by a healthcare provider, they can follow up for a recommendation of an alternative product to use.